Clinical Trial Update: Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US) [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing best implementation practices for injectable cabotegravir + rilpivirine in the United States; study completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• cabotegravir + rilpivirine (injectable) (cabotegravir and rilpivirine)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2022-01-10